Medindia

X

Combined Lumacaftor-Ivacaftor Therapy: Safe and Effective for Cystic Fibrosis Patients

by Bidita Debnath on  May 18, 2015 at 3:33 PM Research News   - G J E 4
Cystic fibrosis, a genetic disease that causes the body to create thick and sticky mucus, can now be controlled, thanks to a new breakthrough research.
Combined Lumacaftor-Ivacaftor Therapy: Safe and Effective for Cystic Fibrosis Patients
Combined Lumacaftor-Ivacaftor Therapy: Safe and Effective for Cystic Fibrosis Patients
Advertisement

In an international clinical trial, treatment with two medications, which targeted the most common genetic cause of cystic fibrosis, improved lung function and lowered the rate of pulmonary exacerbations.

Advertisement
The Combined Lumacaftor-Ivacaftor Therapy was shown to be safe and effective for cystic fibrosis patients.

The mucus formed due to this disease leads to chronic infections and increased loss of lung function. In the pancreas, the thick mucus keeps enzymes from reaching the gut to digest food. The median life expectancy is 37 years, and available treatments mostly focus on managing symptoms and consequences of the disease.

McColly, an Associate Director at the Cystic Fibrosis Center at Lurie Children's said, while significant progress has been made with supportive therapies for cystic fibrosis, developing treatments that address the underlying genetic cause still is a challenge.

The research claims that combining Ivacaftor with Lumacaftor helps patients with the most common cystic fibrosis mutation.

The study is published in the New England Journal of Medicine.

Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All